Test Price
2,800 AED✅ Home Collection Available
CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test in UAE | AED 2,800 | DHA-Regulated
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited next-generation sequencing.
Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test clinical guidance to interpret your results.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The CERS1 gene test detects pathogenic mutations responsible for Progressive Myoclonus Epilepsy Type 8, a rare, inherited neurodegenerative disorder. Using next‑generation sequencing (NGS), this DNA analysis delivers a definitive molecular diagnosis to guide precision neurology interventions.
| Feature | Our CERS1 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | NGS – whole gene coverage including introns and regulatory regions | Sanger sequencing – limited to selected exons |
| Diagnostic Sensitivity | 99.9% for CERS1 variants | ~95% (may miss deep intronic variants) |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I see how a molecular diagnosis can transform clinical management for families living with Progressive Myoclonus Epilepsy Type 8. This test provides a definitive genetic explanation, enabling targeted therapeutic strategies and informed family planning. A negative result does not rule out other epileptic aetiologies, and clinical correlation remains essential.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Do not discontinue any prescribed antiepileptic or other medication without consulting your treating physician. This test is a diagnostic aid, not a replacement for clinical management.
Exclusion Criteria & Emergency Red Flags
- Test is not indicated for asymptomatic minors without prior genetic counselling and parental consent (in line with UAE Federal Law No. 2 of 2019 and Medical Liability Law).
- Severe anaemia, coagulopathy, or active systemic infection may contraindicate blood draw – evaluate clinically.
- If the patient experiences acute neurological deterioration (prolonged seizures, loss of consciousness, or aspiration risk), seek emergency medical care immediately rather than relying on test scheduling.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the CERS1 gene test for Progressive Myoclonus Epilepsy Type 8?
The CERS1 NGS test achieves 99.9% diagnostic sensitivity for detecting pathogenic variants in the CERS1 gene. Our laboratory uses clinically validated bioinformatics pipelines and ISO‑certified protocols to ensure the highest analytical validity, giving neurologists a reliable basis for diagnosis and family counselling.
2. What sample is needed and does the test require any special preparation?
A simple blood draw (venous or FTA card) is accepted; no fasting or medication adjustments are required. A pre‑test genetic counselling session is mandatory to map the family pedigree and discuss potential outcomes, ensuring informed consent and compliance with UAE regulations.
3. How long until I receive the test results?
Results are typically delivered within 3 to 4 weeks from sample receipt, allowing thorough next‑generation sequencing, data analysis, and expert clinical interpretation. We offer telephonic post‑guidance to help you discuss the report with your neurologist.
4. Can home collection be arranged for this genetic test?
Yes. For a standard blood sample (venous or FTA), our VIP mobile phlebotomy service offers temperature-controlled cold-chain home collection daily from 8 AM to 11 PM. However, if a skin biopsy or other surgical specimen is ever required for confirmatory analysis, it would need to be collected in an accredited hospital setting.
5. Is the test covered by insurance?
Coverage varies by insurer. We provide direct billing verification via WhatsApp at +971 54 548 8731. Please contact us with your policy details to check eligibility.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – Strict data privacy and confidentiality.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Secure handling of digital health records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Patient consent and clinical safety standards.
- ISO 9001:2015 Certified Facility – Cert # INT/EGQ/2509DA/3139.
- DHA‑Licensed Laboratory – License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Whole blood (2–5 ml in EDTA tube) or FTA card; home phlebotomy available |
| Methodology Used | Next-Generation Sequencing (NGS) targeting CERS1 gene with 99.9% sensitivity |
| ICD-10-CM Code | G40.3 (Generalized idiopathic epilepsy and epileptic syndromes) |
| LOINC Code | 53832-6 (Genetic analysis of specific gene variant) |
| DHA Facility License & Laboratory Address | License No. 1143 – DNA Labs UAE – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians